This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3cs9
From Proteopedia
m (Protected "3cs9" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
[[Image:3cs9.png|left|200px]] | [[Image:3cs9.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3cs9", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3cs9| PDB=3cs9 | SCENE= }} | {{STRUCTURE_3cs9| PDB=3cs9 | SCENE= }} | ||
===Human ABL kinase in complex with nilotinib=== | ===Human ABL kinase in complex with nilotinib=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_15710326}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 15710326 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_15710326}} | {{ABSTRACT_PUBMED_15710326}} | ||
| Line 24: | Line 13: | ||
*[[Nilotinib|Nilotinib]] | *[[Nilotinib|Nilotinib]] | ||
*[[Proto-oncogene tyrosine-protein kinase|Proto-oncogene tyrosine-protein kinase]] | *[[Proto-oncogene tyrosine-protein kinase|Proto-oncogene tyrosine-protein kinase]] | ||
| - | *[[User:Matt Whelihan|User:Matt Whelihan]] | ||
==Reference== | ==Reference== | ||
Revision as of 19:36, 25 July 2012
Contents |
Human ABL kinase in complex with nilotinib
Template:ABSTRACT PUBMED 15710326
About this Structure
3cs9 is a 4 chain structure of Proto-oncogene tyrosine-protein kinase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Weisberg E, Manley PW, Breitenstein W, Bruggen J, Cowan-Jacob SW, Ray A, Huntly B, Fabbro D, Fendrich G, Hall-Meyers E, Kung AL, Mestan J, Daley GQ, Callahan L, Catley L, Cavazza C, Azam M, Neuberg D, Wright RD, Gilliland DG, Griffin JD. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell. 2005 Feb;7(2):129-41. PMID:15710326 doi:S1535-6108(05)00028-0
Categories: Homo sapiens | Non-specific protein-tyrosine kinase | Cowan-Jacob, S W. | Fabbro, D. | Fendrich, G. | Liebetanz, J. | Manley, P. | Abl | Abl kinase wt in complex with nvp-amn107 | Amn107 | Atp-binding | Cell adhesion | Cytoskeleton | Kinase | Lipoprotein | Magnesium | Manganese | Metal-binding | Myristate | Nilotinib | Nucleotide-binding | Nucleus | Phosphoprotein | Proto-oncogene | Sh2 domain | Sh3 domain | Transferase | Tyrosine-protein kinase
